JAMA Oncology : Surgery vs Radiotherapy in the Management of Gleason Score 9-10 Prostate Cancer and the Risk of Mortality
Interview with Anthony D'Amico, MD, PhD, author of Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 15, 2018 Category: General Medicine Source Type: podcasts

Pembrolizumab for Patients with Advanced NSCLC and a Performance Status (PS) of 2: Results of the PePS2 Trial (BMIC-067)
Dr. Jack West summarizes new information presented at ESMO 2018 on the PePS2 trial of pembrolizumab (Keytruda) in patients with advanced NSCLC performance status (PS) of 2, which demonstrated favorabl... Author: BeaconMedIC Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 14, 2018 Category: Cancer & Oncology Source Type: podcasts

Long-Term Management of Patients Doing Well on Immunotherapy for Advanced NSCLC: Insights from KEYNOTE-010 (BMIC-066)
Dr. Jack West reviews longitudinal outcomes for patients on the KEYNOTE-010 trial of pembrolizumab (Keytruda) vs. docetaxel as 2nd line therapy for advanced NSCLC, with helpful new info on those compl... Author: BeaconMedIC Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 14, 2018 Category: Cancer & Oncology Source Type: podcasts

ADD-What are myeloma warriors?
In this weeks video, Dr. Brian G.M. Durie talks about ways myeloma patients, caregivers, or family members can give back to the myeloma community.The BOTTOM LINE: The Myeloma Warrior Spirit means... Author: InternationalMyelomaFoundation Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2018 Category: Cancer & Oncology Source Type: podcasts

ADD-How important is the FDA approval of once weekly dosage of Kyprolis for multiple myeloma patients?
In this weeks video, Dr. Brian G.M. Durie explains the results of the A.R.R.O.W. trial, which proved the efficacy and safety of once-a-week dosing of Kyprolis for myeloma patients.BOTTOM LINE: ... Author: InternationalMyelomaFoundation Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2018 Category: Cancer & Oncology Source Type: podcasts

ADD-How is the IMFs Black Swan Research Initiative working to find a cure for multiple myeloma?
In this weeks video, Dr. Brian G.M. Durie discusses the Black Swan Research Initiatives 3 Cure trials, which use new treatment protocols. The BOTTOM LINE: Using new treatment protocols wi... Author: InternationalMyelomaFoundation Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2018 Category: Cancer & Oncology Source Type: podcasts

ADD-What is the latest on a new drug called selinexor
In this weeks video, Dr. Brian G.M. Durie details the results of the STORM 2b trial, which uses selinexor in combination with dexamethasone to treat multiple myeloma patients who are refractory to IM... Author: InternationalMyelomaFoundation Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2018 Category: Cancer & Oncology Source Type: podcasts

ADD-How does the FDA approval of NGS to test for MRD in multiple myeloma affect patients?
In this weeks video, Dr. Durie discusses the two main types of minimal residual disease (MRD) tests for multiple myeloma next-generation sequencing (NGS) and next-generation flow (NGF).The BOTT... Author: InternationalMyelomaFoundation Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2018 Category: Cancer & Oncology Source Type: podcasts

ADD-If you have myeloma should you undergo tests for DNA sequencing
In this weeks video, Dr. Brian G.M. Durie comments on why it is not necessary for multiple myeloma patients to have their DNA sequenced.BOTTOM LINE: For myeloma patients, DNA sequencing is helpfu... Author: InternationalMyelomaFoundation Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2018 Category: Cancer & Oncology Source Type: podcasts

ADD-If a myeloma patient has MRD-negative status does that mean that patient is cured
In this video, Dr. Brian G.M. Durie explains how researchers are studying minimal residual disease (MRD) testing further to better understand sustained MRD-negativity.The BOTTOM LINE: MRD-negative... Author: InternationalMyelomaFoundation Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2018 Category: Cancer & Oncology Source Type: podcasts

ADD - How is high-risk smoldering multiple myeloma diagnosed?
In this video, Dr. Brian G.M. Durie explains that active myeloma is diagnosed if a patient has CRAB features and myeloma-defining events. He also sheds light on a new set of criteria for high-risk smo... Author: InternationalMyelomaFoundation Added: 11/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 13, 2018 Category: Cancer & Oncology Source Type: podcasts

Mark T. Reding, MD - Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - November 12, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Bayer Xofigo Program
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Xofigo Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018. Author: Cancer-News Added: 11/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Bayer Stivarga Program
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Stivarga Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018. Author: Cancer-News Added: 11/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Bayer Regorafenib Program
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Regorafenib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018. Author: Cancer-News Added: 11/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Bayer Copanlisib Program
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Copanlisib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018. Author: Cancer-News Added: 11/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2018 Category: Cancer & Oncology Source Type: podcasts

The Impact Of The Psychosocial Milieu On Quality Of Life And Survival
CRISTIANE DECAT BERGEROT, PhDPSYCHOLOGIST, POSTDOCTORAL FELLOWCITY OF HOPE COMPREHENSIVE CANCER CENTER discusses THE IMPACT OF THE PSYCHOSOCIAL MILIEU ON QUALITY OF LIFE AND SURVIVAL At the Sevent... Author: kidneycancer Added: 11/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Ethical Issues in Kidney Cancer Research and Treatment
Eric A. Singer, MD, MA, MS, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Section of Urologic Oncology Rutgers Cancer Institute of New Jersey Director, Distinction ... Author: kidneycancer Added: 11/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Incorporating Relevant and Meaningful Patient-Reported Outcomes in RCC Clinical Trials
Bellinda King-Kallimanis, PhD of U.S. Food and Drug Administration, Maryland (FDA ) discusses Incorporating Relevant and Meaningful Patient-Reported Outcomes in RCC Clinical Trials at the Seventeen... Author: kidneycancer Added: 11/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 8, 2018 Category: Cancer & Oncology Source Type: podcasts

Patient And Physician PerspectiveMatching, Overlapping, Or None Of The Above?
Andr P. Fay, MD, PhD Professor, PUCRS School of Medicine Chief, Medical Oncology Department - Hospital So Lucas da PUCRS/ Oncoclnicas Porto Alegre Visiting Scientist at Dana-Farber Cancer Institut... Author: kidneycancer Added: 11/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 8, 2018 Category: Cancer & Oncology Source Type: podcasts

Tracking Renal Cancer Evolution Through Space And Time: Implications For Patient Management
Samra Turajlic BA, MBBS, MRCP, PhD, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust, London Cancer Research UK Clinician Scientist, Francis Crick Institute, London discusses Trackin... Author: kidneycancer Added: 11/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 8, 2018 Category: Cancer & Oncology Source Type: podcasts

Cytoreductive nephrectomy Placing recent clinical trials in context
E. Jason Abel MD, FACS University of Wisconsin discusses Cytoreductive nephrectomy Placing recent clinical trials in context at the Seventeenth International Kidney Cancer International Sym... Author: kidneycancer Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Updated Results on PACIFIC Trial: Should we Revise Who Should Receive Consolidation Immunotherapy after Chemo/Radiation? (BMIC-065)
Dr. Jack West discusses the trial design of the PACIFIC trial of consolidation durvalumab (Imfinzi) after chemo/radiation for unresectable stage III NSCLC and highlights new data on overall survival a... Author: BeaconMedIC Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Key Insights in Lymphoma: from Lymphoma & Myeloma 2018
Earn CME: https://naccme.com/program/...In this Key Insights activity, Drs. Morton Coleman and John P. Leonard discuss highlights in lymphoma from Lymphoma & Myeloma 2018: An International Congr... Author: imedex Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Key Insights in Chronic Lymphocytic Leukemia: from Lymphoma & Myeloma 2018
Earn CME: https://naccme.com/program/...In this Key Insights activity, Drs. Morton Coleman and Richard R. Furman discuss CLL-related highlights from Lymphoma & Myeloma 2018: An International Con... Author: imedex Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Key Insights in Multiple Myeloma: from Lymphoma & Myeloma 2018
Earn CME: https://naccme.com/program/...In this Key Insights activity, Drs. Morton Coleman and Ruben Niesvizky discuss myeloma presentation highlights from Lymphoma & Myeloma 2018: An Internatio... Author: imedex Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

NSCLC: Interactive Case-based Panel Discussion
Earn CME Credit: https://naccme.com/program/...In this presentation from the 23rd Annual Perspectives in Thoracic Oncology, Drs. Langer, Aggarwal, Bazhenova, and Ross examine a series of NSCLC ca... Author: imedex Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Understanding, preventing, and delaying EGFR resistance in the era of Osimertinib
Earn CME Credit: https://naccme.com/program/...In this presentation from the 23rd Annual Perspectives in Thoracic Oncology, Dr. Lyudmila Bazhenova discusses EGFR resistance in the era of osimerti... Author: imedex Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Targeted treatment with EGFR TKIs: Front line options
Earn CME Credit: https://naccme.com/program/...In this presentation from the 23rd Annual Perspectives in Thoracic Oncology, Dr. Charu Aggarwal discusses frontline options for targeted therapy wit... Author: imedex Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Heterogeneity of NSCLC and precipitating oncogenic driver mutations
Earn CME Credit: https://naccme.com/program/...In this presentation from the 23rd Annual Perspectives in Thoracic Oncology, Dr. Helen Ross discusses the heterogeneity of NSCLC and precipitating o... Author: imedex Added: 11/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Novick Memorial Lecture Heterogeneity of Renal Cell Carcinoma: Lessons learned from biopsy and active surveillance of small renal masses (SRM)
Michael A.S. Jewett DEPARTMENT OF SURGICAL ONCOLOGY PRINCESS MARGARET CANCER CENTRE DIVISION OF UROLOGY THE UNIVERSITY OF TORONTO discusses Heterogeneity of Renal Cell Carcino... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Ipilimumab plus Nivolumab as Salvage Therapy in Patients with Checkpoint Inhibitor-Refractory Metastatic Renal Cell Carcinoma
Kimberly Allman, MSN, CNP Cleveland Clinic Taussig Cancer Institute discusses Ipilimumab plus Nivolumab as Salvage Therapy in Patients with Checkpoint Inhibitor-Refractory Metastatic... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Second-Line VEGFR TKI Outcomes After First-Line Immune Checkpoint Blockade in Metastatic Renal Cell Carcinoma
Ritesh Kotecha discusses Second-Line VEGFR TKI Outcomes After First-Line Immune Checkpoint Blockade in Metastatic Renal Cell Carcinoma at the Seventeenth International Kidney Cancer Inte... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:Results of the dose-escalation stage in patients with treatment-nave advanced renal cell carcinoma
Neeraj Agarwal Huntsman Cancer Center discusses Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:Results of the dose-escalation stage in patients with treatment-nave adv... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Updates latin american cooperative oncology group (lacog)
Andrey Soares Medical Oncologist Centro Paulista de Oncologia and Hospital Israelita Albert Einstein SPChair LACOG GU gives an UPDATES LATIN AMERICAN COOPERATIVE ONCOLOGY GROUP ... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

LARCG Latin American Renal Cancer Group
Rodolfo Borges dos Reis, MD, PhD Uro-oncology Ribeirao Preto Medical School discusses LARCG Latin American Renal Cancer Group at the Seventeenth International Kidney Cancer International S... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Whole Body MRI for Detection of Renal Cell Carcinoma Osseous Metastases
Alberto Diaz de Leon M.D. discusses Whole Body MRI for Detection of Renal Cell Carcinoma Osseous Metastases at the Seventeenth International Kidney Cancer International Symposium 2018 in... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Targeting Vulnerabilities Arising from Dysregulated Histone Demethylase Function in Kidney Cancer
Abhishek A. Chakraborty Instructor in Medicine Department of Medical Oncology Laboratory of William Kaelin Dana-Farber Cancer Institute Harvard Medical School discusses Targeting ... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

A Secreted PD-L1 Splice Variant that Covalently Dimerizes and Mediates Immunosuppression
Kathleen Mahoney, M.D., Ph.D. Instructor of Medicine, Harvard Medical School Attending, Beth Israel Deaconess Medical Center Research Fellow, Dana Farber Cancer Institute discusse... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Novel metabolic insights into RCC biology and immune response
A Ari Hakimi MD Assistant Member, Department of Surgery, Urology Service Member, Immunogenomics and Precision Oncology Platform discusses the Novel metabolic insights into RCC bi... Author: kidneycancer Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Neovax: From Translation to Bedside
Toni K. Choueiri, MD Director, Lank Center for Genitourinary Oncology Department of Medical Oncology Dana-Farber Cancer Institute discusses Neovax: From Translation to Bedside From the Seventeenth Int... Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Targeting Epigenetics and Chromatin Remodeling Genes
Thai H. Ho, MD, PhD Mayo Clinic Arizona discusses Targeting Epigenetics and Chromatin Remodeling Genes From the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL. Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

The Next Therapeutic Targets: TGFbeta
Thomas Powles Director of Barts Cancer Centre discusses The next therapeutic targets: TGFbeta From the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL. Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Adenosine Pathway Inhibitors
Abhishek Tripathi MD Assistant Professor of Medicine University of Oklahoma Stephenson Cancer Center discusses Adenosine Pathway Inhibitors From the Seventeenth International Kidney Cancer Internation... Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Exploiting oncometabolite-induced DNA repair defects
Ranjit S. Bindra, M.D., Ph.D. Associate Professor Departments of Therapeutic Radiology and Experimental Pathology Yale Cancer Center discusses Exploiting oncometabolite-induced DNA repair defects Fro... Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

IMpower133: Is there Finally a New Standard of Care for Extensive Stage SCLC? (BMIC-064)
Dr. Jack West reviews the IMpower133 trial that integrated atezolizumab with first line chemo for extensive stage SCLC and discusses whether the results improve outcomes enough to change our standard ... Author: BeaconMedIC Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Engaging Clinical Trialists in the Community Setting
Suzanne Cole, MD FACP Medical Director, Community Cancer Clinic Richardson Plano UT Southwestern Medical Center discusses Engaging Clinical Trialists in the Community Setting From the Seventeenth Inte... Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Creating Synergy in RCC: Collaborative Approaches to Value
Robert G. Uzzo, M.D. Willing G. Pepper Chairman of Surgery Fox Chase Cancer Center Temple University School of Medicine Chair, Department of Urology Urological Institute at Einstein Healthcare Network... Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

What is the Next Cytoreductive Surgical Trial?
Hyung L. Kim, M.D. Director, Academic Urology Programs Cedars Sinai Medical Center discusses What is the Next Cytoreductive Surgical Trial? From the Seventeenth International Kidney Cancer Internation... Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Combination Checkpoint Blockade with Surgery
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology MD Anderson Cancer Center discusses Combination Checkpoint Blockade with Surgery From the Seven... Author: kidneycancer Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 5, 2018 Category: Cancer & Oncology Source Type: podcasts